📣 VC round data is live. Check it out!

Pilulka Lekarny Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pilulka Lekarny and similar public comparables like Digital Brands Group, MOGU, Westwing Brasil, Laxus Technologies and more.

Pilulka Lekarny Overview

About Pilulka Lekarny

Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.


Founded

2014

HQ

Czech Republic

Employees

N/A

Website

pilulka.cz

Financials (FY)

Revenue: $63M
EBITDA: ($2M)

EV

$19M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pilulka Lekarny Financials

Pilulka Lekarny reported last fiscal year revenue of $63M and negative EBITDA of ($2M).

In the same fiscal year, Pilulka Lekarny generated $6M in gross profit, ($2M) in EBITDA losses, and had net loss of ($6M).


Pilulka Lekarny P&L

In the most recent fiscal year, Pilulka Lekarny reported revenue of $63M and EBITDA of ($2M).

Pilulka Lekarny is unprofitable as of last fiscal year, with gross margin of 9%, EBITDA margin of (4%), and net margin of (10%).

See analyst estimates for Pilulka Lekarny
Last FY20232024202620272028
Revenue$63M$102M$63M
Gross Profit$6M$8M$6M
Gross Margin9%8%9%
EBITDA($2M)($4M)($2M)
EBITDA Margin(4%)(4%)(4%)
EBIT Margin(7%)(7%)(7%)
Net Profit($6M)($8M)($6M)
Net Margin(10%)(8%)(10%)
Net Debt$2M--

Financial data powered by Morningstar, Inc.

Pilulka Lekarny Stock Performance

Pilulka Lekarny has current market cap of $17M, and enterprise value of $19M.

Market Cap Evolution


Pilulka Lekarny's stock price is $6.28.

Pilulka Lekarny share price decreased by 1.8% in the last 30 days, and by 33.2% in the last year.

Pilulka Lekarny has an EPS (earnings per share) of $-2.23.

See more trading valuation data for Pilulka Lekarny
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$19M$17M-3.1%-1.8%23.2%-33.2%$-2.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pilulka Lekarny Valuation Multiples

Pilulka Lekarny trades at 0.3x EV/Revenue multiple, and (7.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Pilulka Lekarny

Pilulka Lekarny Financial Valuation Multiples

As of June 3, 2026, Pilulka Lekarny has market cap of $17M and EV of $19M.

Pilulka Lekarny has a P/E ratio of (2.8x).

Last FY20232024202620272028
EV/Revenue0.3x0.2x0.3x
EV/EBITDA(7.9x)(4.3x)(7.9x)
EV/EBIT(4.1x)(2.7x)(4.1x)
EV/Gross Profit3.4x2.3x3.4x
P/E(2.8x)(2.0x)(2.8x)
EV/FCF(6.0x)(5.6x)(6.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pilulka Lekarny Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pilulka Lekarny Margins & Growth Rates

In the most recent fiscal year, Pilulka Lekarny reported gross margin of 9%, EBITDA margin of (4%), and net margin of (10%).

See estimated margins and future growth rates for Pilulka Lekarny

Pilulka Lekarny Margins

Last FY2024202720282029
Gross Margin9%9%
EBITDA Margin(4%)(4%)
EBIT Margin(7%)(7%)
Net Margin(10%)(10%)
FCF Margin(5%)(5%)

Pilulka Lekarny Growth Rates

23/2426/2727/2828/29
Revenue Growth(39%)
Gross Profit Growth(32%)
EBITDA Growth(46%)
EBIT Growth(35%)
Net Profit Growth(28%)
FCF Growth(7%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Pilulka Lekarny Operational KPIs

Access forward-looking KPIs for Pilulka Lekarny
Last FY20232024202620272028
Opex to Revenue16%15%16%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pilulka Lekarny Competitors

Pilulka Lekarny competitors include Digital Brands Group, MOGU, Westwing Brasil, Laxus Technologies, Farmacosmo, Goodfood Market, MedTech Solutions, MERLIN GROUP, Rise and Moliera2.

Most Pilulka Lekarny public comparables operate across Consumer E-commerce, Pharmacies, Vertical E-commerce and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Digital Brands Group----
MOGU(2.1x)-7.0x-
Westwing Brasil(0.1x)-(1.9x)-
Laxus Technologies0.9x1.0x2.6x-
Farmacosmo0.4x-63.4x-
Goodfood Market0.5x0.6x10.5x43.1x
MedTech Solutions148.0x-(17.9x)-
MERLIN GROUP----

This data is available for Pro users. Sign up to see all Pilulka Lekarny competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pilulka Lekarny

When was Pilulka Lekarny founded?Pilulka Lekarny was founded in 2014.
Where is Pilulka Lekarny headquartered?Pilulka Lekarny is headquartered in Czech Republic.
Is Pilulka Lekarny publicly listed?Yes, Pilulka Lekarny is a public company listed on Prague Stock Exchange.
What is the stock symbol of Pilulka Lekarny?Pilulka Lekarny trades under PINK ticker.
When did Pilulka Lekarny go public?Pilulka Lekarny went public in 2020.
Who are competitors of Pilulka Lekarny?Pilulka Lekarny main competitors include Digital Brands Group, MOGU, Westwing Brasil, Laxus Technologies, Farmacosmo, Goodfood Market, MedTech Solutions, MERLIN GROUP, Rise, Moliera2.
What is the current market cap of Pilulka Lekarny?Pilulka Lekarny's current market cap is $17M.
What is the current revenue of Pilulka Lekarny?Pilulka Lekarny's last fiscal year revenue is $63M.
What is the current EV/Revenue multiple of Pilulka Lekarny?Current revenue multiple of Pilulka Lekarny is 0.3x.
Is Pilulka Lekarny profitable?No, Pilulka Lekarny is not profitable.
How many companies Pilulka Lekarny has acquired to date?Pilulka Lekarny hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Pilulka Lekarny has invested to date?Pilulka Lekarny hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Pilulka Lekarny

Lists including Pilulka Lekarny

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial